Literature DB >> 18284469

Dissection of spontaneous cytotoxicity by human intestinal intraepithelial lymphocytes: MIC on colon cancer triggers NKG2D-mediated lysis through Fas ligand.

Ellen C Ebert1, Veronika Groh.   

Abstract

Human intestinal intraepithelial lymphocytes (IELs), which are T-cell receptor alphabeta+ CD8+ T cells located between epithelial cells (ECs), are likely to participate in the innate immune response against colon cancer. IELs demonstrate spontaneous cytotoxic (SC) activity specifically directed against EC tumours but not against other solid tumour types. The aim of this study was to dissect out the mechanism of SC activity, focusing on the interaction of NKG2D on IELs with its ligands [major histocompatibility complex (MHC) class I chain-related protein (MIC) and UL16 binding protein (ULBP)] found mainly on EC tumours. A novel series of events occurred. The NKG2D-MIC/ULBP interaction induced Fas ligand (FasL) production and FasL-mediated SC activity against HT-29 cells and MIC-transfectants. Tumour necrosis factor-alpha and interferon-gamma, produced independently of this interaction, promoted SC activity. The immune synapse was strengthened by the interaction of CD103 on IELs with E-cadherin on HT-29 cells. Neither T-cell receptor nor MHC class I was involved. While the HT-29 cells were destroyed by soluble FasL, tumour necrosis factor-alpha and interferon-gamma, the IELs were resistant to the effects of these mediators and to FasL expressed by the HT-29 cells. This unidirectional FasL-mediated cytotoxicity of IELs against HT-29 cells, triggered through NKG2D, is unique and is likely to be a property of those CD8+ tumour-infiltrating lymphocytes that phenotypically resemble IELs.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18284469      PMCID: PMC2434382          DOI: 10.1111/j.1365-2567.2007.02656.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  36 in total

Review 1.  Roles of the NKG2D immunoreceptor and its ligands.

Authors:  David H Raulet
Journal:  Nat Rev Immunol       Date:  2003-10       Impact factor: 53.106

2.  NK cell CD94/NKG2A inhibitory receptors are internalized and recycle independently of inhibitory signaling processes.

Authors:  Francisco Borrego; Juraj Kabat; Tolib B Sanni; John E Coligan
Journal:  J Immunol       Date:  2002-12-01       Impact factor: 5.422

3.  Exposure of human primary colon carcinoma cells to anti-Fas interactions influences the emergence of pre-existing Fas-resistant metastatic subpopulations.

Authors:  Kebin Liu; Elwood McDuffie; Scott I Abrams
Journal:  J Immunol       Date:  2003-10-15       Impact factor: 5.422

4.  Expression of nonclassical class I molecules by intestinal epithelial cells.

Authors:  Lilani Perera; Ling Shao; Anjlee Patel; Kelly Evans; Bertrand Meresse; Richard Blumberg; Daniel Geraghty; Veronika Groh; Thomas Spies; Bana Jabri; Lloyd Mayer
Journal:  Inflamm Bowel Dis       Date:  2007-03       Impact factor: 5.325

5.  Same peculiar subset of HML1 + lymphocytes present within normal intestinal epithelium is associated with tumoral epithelium of gastrointestinal carcinomas.

Authors:  A Jarry; N Cerf-Bensussan; N Brousse; D Guy-Grand; F Muzeau; F Potet
Journal:  Gut       Date:  1988-12       Impact factor: 23.059

6.  Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation.

Authors:  Veronika Groh; Jennifer Wu; Cassian Yee; Thomas Spies
Journal:  Nature       Date:  2002-10-17       Impact factor: 49.962

7.  Cutting edge: tumor rejection mediated by NKG2D receptor-ligand interaction is dependent upon perforin.

Authors:  Yoshihiro Hayakawa; Janice M Kelly; Jennifer A Westwood; Phillip K Darcy; Andreas Diefenbach; David Raulet; Mark J Smyth
Journal:  J Immunol       Date:  2002-11-15       Impact factor: 5.422

8.  NKG2D engagement of colorectal cancer-specific T cells strengthens TCR-mediated antigen stimulation and elicits TCR independent anti-tumor activity.

Authors:  Cristina Maccalli; Daniela Pende; Chiara Castelli; Maria Cristina Mingari; Paul F Robbins; Giorgio Parmiani
Journal:  Eur J Immunol       Date:  2003-07       Impact factor: 5.532

9.  Elevated TGF-beta1 secretion and down-modulation of NKG2D underlies impaired NK cytotoxicity in cancer patients.

Authors:  June-Chul Lee; Kyung-Mi Lee; Dong-Wan Kim; Dae Seog Heo
Journal:  J Immunol       Date:  2004-06-15       Impact factor: 5.422

10.  Restored T-cell activation mechanisms in human tumour-infiltrating lymphocytes from melanomas and colorectal carcinomas after exposure to interleukin-2.

Authors:  F De Paola; R Ridolfi; A Riccobon; E Flamini; F Barzanti; A M Granato; G L Mordenti; L Medri; P Vitali; D Amadori
Journal:  Br J Cancer       Date:  2003-01-27       Impact factor: 7.640

View more
  6 in total

1.  Regulation of NKG2D+CD8+ T-cell-mediated antitumor immune surveillance: Identification of a novel CD28 activation-mediated, STAT3 phosphorylation-dependent mechanism.

Authors:  Jiemiao Hu; Izhar S Batth; Xueqing Xia; Shulin Li
Journal:  Oncoimmunology       Date:  2016-11-01       Impact factor: 8.110

2.  Irradiation-induced up-regulation of HLA-E on macrovascular endothelial cells confers protection against killing by activated natural killer cells.

Authors:  Isabelle Riederer; Wolfgang Sievert; Günther Eissner; Michael Molls; Gabriele Multhoff
Journal:  PLoS One       Date:  2010-12-16       Impact factor: 3.240

3.  Interleukin 21 up-regulates perforin-mediated cytotoxic activity of human intra-epithelial lymphocytes.

Authors:  Ellen C Ebert
Journal:  Immunology       Date:  2009-06       Impact factor: 7.397

4.  Cervical cancer cell lines expressing NKG2D-ligands are able to down-modulate the NKG2D receptor on NKL cells with functional implications.

Authors:  Miriam I Jimenez-Perez; Luis F Jave-Suarez; Pablo C Ortiz-Lazareno; Alejandro Bravo-Cuellar; Oscar Gonzalez-Ramella; Adriana Aguilar-Lemarroy; Georgina Hernandez-Flores; Ana L Pereira-Suarez; Adrian Daneri-Navarro; Susana del Toro-Arreola
Journal:  BMC Immunol       Date:  2012-02-08       Impact factor: 3.615

5.  Improved production of recombinant human Fas ligand extracellular domain in Pichia pastoris: yield enhancement using disposable culture-bag and its application to site-specific chemical modifications.

Authors:  Michiro Muraki
Journal:  BMC Biotechnol       Date:  2014-03-11       Impact factor: 2.563

Review 6.  Mechanisms of activation of innate-like intraepithelial T lymphocytes.

Authors:  Maud Vandereyken; Olivia J James; Mahima Swamy
Journal:  Mucosal Immunol       Date:  2020-05-15       Impact factor: 7.313

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.